Importance of genotypic and phenotypic tolerance in the treatment of experimental endocarditis due to Streptococcus gordonii

Journal of Infectious Diseases

Volumn 175, Issue 1, 1997, Pages 70-76

  Entenza, José M ^a   Caldelari, Isabelle ^a   Glauser, Michel P ^a   Francioli, Patrick ^a   Moreillon, Philippe ^a  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

BETA LACTAM ANTIBIOTIC;

ANIMAL CELL; ARTICLE; BACTERIAL GROWTH; BACTERICIDAL ACTIVITY; CELL KILLING; DRUG TOLERANCE; ENDOCARDITIS; EXPERIMENTAL INFECTION; GENOTYPE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; STREPTOCOCCUS GORDONII; TREATMENT FAILURE;

EID: 0031015269     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1093/infdis/175.1.70     Document Type: Article

References (14)

1. Tomasz A, Albino A, Zanati E. Multiple antibiotic resistance in a bacterium with suppressed autolytic system. Nature 1970;227:138-40.
2. Handwerger S, Tomasz A. Antibiotic tolerance among clinical isolates of bacteria. Rev Infect Dis 1985;7:368-86.
3. Moreillon P, Markiewicz Z, Nachman S, Tomasz A. Two bactericidal targets for penicillin in pneumococci: autolysis dependent and autolysis independent killing mechanisms. Antimicrob Agents Chemother 1990; 34:33-9.
4. Liu HH, Tomasz A. Penicillin tolerance in multiple drug-resistant natural isolates of Streptococcus pneumoniae. J Infect Dis 1985; 152:365-72.
5. Tuomanen E. Phenotypic tolerance: the search for β-lactam antibiotics that kill nongrowing bacteria. Rev Infect Dis 1986;8(suppl 3):S279-91.
6. Meylan P, Francioli P, Glauser MP. Discrepancies between MBC and actual killing of viridans streptococci by cell-wall active antibiotics. Antimicrob Agents Chemother 1986;29:418-23.
7. Sherris JC. Problems in in vitro determination of antibiotic tolerance in clinical isolates. Antimicrob Agents Chemother 1986;30:633-7.
8. Sabath LD, Mokhbat JE. What is the clinical significance of tolerance to β-lactam antibiotics? In: Remington JS, Swartz MM, eds. Current clinical topics in infectious diseases. New York: McGraw-Hill, 1983;358-77.
9. Goldman PL, Petersdof RG. Significance of methicillin tolerance in experimental staphylococcal endocarditis. Antimicrob Agents Chemother 1979;15:802-6.
10. Pulliam L, Inokuchi S, Hadley WK, Mills J. Penicillin tolerance in experimental streptococcal endocarditis. Lancet 1979;3:957.
11. Lowy FD, Neuhaus EG, Chang DS, Steigbigel NH. Penicillin therapy of experimental endocarditis induced by tolerant Streptococcus sanguis and non-tolerant Streptococcus mitis. Antimicrob Agents Chemother 1983;23:67-73.
12. Brennan RO, Durack DT. Therapeutic significance of penicillin tolerance in experimental streptococcal endocarditis. Antimicrob Agents Chemother 1983;23:273-7.
13. Wilson WR, Zak O, Sande MA. Penicillin therapy for treatment of experimental endocarditis caused by viridans streptococci in animals. J Infect Dis 1985;151:1028-33.
14. Voorn GP, Thompson J, Goessens WHF, Schmal-Bauer W, Broeders PHM, Michel MF. Role of tolerance in cloxacillin treatment of experimental Staphylococcus aureus endocarditis. J Infect Dis 1991;163: 640-3.